COMPANY

Apogee Biotechnology

HQ: Hummelstown, PA source · apogee-biotech.com ↗ · Mid-Atlantic

Apogee is developing orally available, small molecules for the treatment of cancer and inflammatory diseases. From company website Source · Oct 12, 2026

Keywords: small molecule

Location: Hummelstown, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

40NIH grants

NIH awards 40

Annual award amounts. Total $15.6M.

Jul 3, 2024 NIH award 5R44AI179348-02 FY2024: $882,744 awarded for that fiscal year; activity R44 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Opaganib as a Medical Counte source ↗
Jul 19, 2023 NIH award 1R44AI179348-01 FY2023: $852,174 awarded for that fiscal year; activity R44 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Opaganib as a Medical Counte source ↗
Jul 19, 2019 NIH award 1R43CA235804-01A1 FY2019: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Treatment of Neuroblastoma source ↗
Aug 10, 2017 NIH award 5R44CA199767-03 FY2017: $653,219 awarded for that fiscal year; activity R44 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Clinical Trial of ABC294640 source ↗
Aug 26, 2016 NIH award 5R42CA183708-05 FY2016: $133,116 awarded for that fiscal year; activity R42 (STTR); PI PARSONS, CHRISTOPHER H; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. An Early-Phase Clinica source ↗
Aug 2, 2016 NIH award 5R44CA199767-02 FY2016: $659,861 awarded for that fiscal year; activity R44 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Clinical Trial of ABC294640 source ↗
Aug 28, 2015 NIH award 1R44CA199767-01 FY2015: $666,666 awarded for that fiscal year; activity R44 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Clinical Trial of ABC294640 source ↗
Aug 4, 2015 NIH award 5R42CA183708-04 FY2015: $499,411 awarded for that fiscal year; activity R42 (STTR); PI PARSONS, CHRISTOPHER H; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. An Early-Phase Clinica source ↗
Jul 1, 2015 NIH award 1R43CA192414-01A1 FY2015: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI SCHRECENGOST, RANDY; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Radiosensitizing Prosta source ↗
Sep 17, 2014 NIH award 2R42CA183708-03A1 FY2014: $509,024 awarded for that fiscal year; activity R42 (STTR); PI PARSONS, CHRISTOPHER H; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. An Early-Phase Clini source ↗
Jun 9, 2014 NIH award 1R43DK101146-01 FY2014: $224,116 awarded for that fiscal year; activity R43 (SBIR); PI SMITH, CHARLES D; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Protection Against Chemother source ↗
2014 NIH contract (government contract; not a grant and not an investment round) 261201400016C-0-0-1 FY2014: $200,000 awarded for that fiscal year; activity N01 (OTHER_NIH); PI SMITH, CHARLES; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. source ↗
Nov 29, 2013 NIH award 5R43AI098309-02 FY2014: $293,448 awarded for that fiscal year; activity R43 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Mitigation of Radiation-Induce source ↗
Jan 7, 2013 NIH award 1R43AI098309-01A1 FY2013: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Mitigation of Radiation-Indu source ↗
Aug 6, 2012 NIH award 1R43DK096685-01 FY2012: $316,916 awarded for that fiscal year; activity R43 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Treatment of Inflammatory Bowe source ↗
Aug 6, 2012 NIH award 1R01FD004102-01 FY2012: $200,000 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Phase 1 Study of ABC29464 source ↗
Mar 10, 2011 NIH award 5R41AI087167-02 FY2011: $300,000 awarded for that fiscal year; activity R41 (STTR); PI PARSONS, CHRISTOPHER H; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Lipid Metabolism and K source ↗
Jun 29, 2010 NIH award 5R41DK084632-02 FY2010: $268,141 awarded for that fiscal year; activity R41 (STTR); PI ZHONG, ZHI; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Improvement of Liver Transplantati source ↗
Mar 30, 2010 NIH award 1R41AI087167-01A1 FY2010: $300,000 awarded for that fiscal year; activity R41 (STTR); PI PARSONS, CHRISTOPHER H; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Lipid Metabolism and source ↗
Sep 18, 2009 NIH award 1R41CA132413-01A2 FY2009: $260,988 awarded for that fiscal year; activity R41 (STTR); PI BEESON, CRAIG CANO; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Optimization of dipeptid source ↗
Aug 17, 2009 NIH award 1R41DK084632-01 FY2009: $258,766 awarded for that fiscal year; activity R41 (STTR); PI ZHONG, ZHI; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Improvement of Liver Transplantati source ↗
Feb 24, 2009 NIH award 5R44AR052261-03 FY2009: $515,195 awarded for that fiscal year; activity R44 (SBIR); PI FITZPATRICK, LEO ROBERT; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Sphingosine Kinase In source ↗
Jun 17, 2008 NIH award 5R44EY016608-03 FY2008: $921,669 awarded for that fiscal year; activity R44 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Sphingosine Kinase Inhibitors source ↗
Mar 14, 2008 NIH award 2R44AR052261-02A1 FY2008: $481,447 awarded for that fiscal year; activity R44 (SBIR); PI FITZPATRICK, LEO ROBERT; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, HUMMELSTOWN, PA. Sphingosine Kinase source ↗
Aug 13, 2007 NIH award 5R44DK071395-03 FY2007: $874,563 awarded for that fiscal year; activity R44 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Sphingosine Kinase Inhibitors source ↗
Jun 25, 2007 NIH award 2R44EY016608-02 FY2007: $953,134 awarded for that fiscal year; activity R44 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Sphingosine Kinase Inhibitors source ↗
Sep 27, 2006 NIH award 1R43HL083765-01A1 FY2006: $219,476 awarded for that fiscal year; activity R43 (SBIR); PI MAINES, LYNN; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Anti-Atherosclerosis Agents Ta source ↗
Aug 18, 2006 NIH award 2R44DK071395-02 FY2006: $819,846 awarded for that fiscal year; activity R44 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Sphingosine Kinase Inhibitors source ↗
Sep 26, 2005 NIH award 1R43DK071395-01A1 FY2005: $176,603 awarded for that fiscal year; activity R43 (SBIR); PI MAINES, LYNN W; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Sphingosine Kinase Inhibitor source ↗
Jun 7, 2005 NIH award 5R43CA110071-02 FY2005: $298,556 awarded for that fiscal year; activity R43 (SBIR); PI DUCKER, CHARLES E; recipient as written: APOGEE BIOTECHNOLOGY CORPORATION, Hummelstown, PA. Inhibitors of Human Pal mit source ↗